0001209191-20-036491.txt : 20200612
0001209191-20-036491.hdr.sgml : 20200612
20200612214222
ACCESSION NUMBER: 0001209191-20-036491
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200612
FILED AS OF DATE: 20200612
DATE AS OF CHANGE: 20200612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HALE DAVID F
CENTRAL INDEX KEY: 0001024004
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36284
FILM NUMBER: 20961782
MAIL ADDRESS:
STREET 1: 1042-B NORTH EL CAMINO REAL, SUITE 430
CITY: ENCINITAS
STATE: CA
ZIP: 92024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCEPT INC
CENTRAL INDEX KEY: 0001044378
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 800943522
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5810 NANCY RIDGE DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-320-8200
MAIL ADDRESS:
STREET 1: 5810 NANCY RIDGE DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-12
0
0001044378
BIOCEPT INC
BIOC
0001024004
HALE DAVID F
C/O BIOCEPT, INC.
5810 NANCY RIDGE DRIVE #150
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2020-06-12
4
S
0
159
0.5578
D
3477
I
By LLC
Common Stock
2020-06-12
4
S
0
445
0.5545
D
112
I
By trust
Common Stock
2020-06-12
4
S
0
556
0.555
D
867
D
The sales reported herein were made for tax planning purposes.
On July 6, 2018, the Issuer effected a 1-for-30 reverse stock split resulting in the reporting person's ownership of 105,463 fewer shares.
On July 6, 2018, the Issuer effected a 1-for-30 reverse stock split resulting in the reporting person's ownership of 16,179 fewer shares.
On July 6, 2018, the Issuer effected a 1-for-30 reverse stock split resulting in the reporting person's ownership of 41,295 fewer shares.
/s/ Michael Nall, Attorney-in-Fact
2020-06-12